Mr. Curtis (Joe) is a senior executive with 25 years of extensive experience in regulatory & clinical affairs along with quality assurance within the medical device market. He has developed and implemented key regulatory and clinical strategies for both pre- and post-market activities. Experience includes Class I, II and III medical devices that have been both disposable and implantable technologies. He has Pre-Market Approval experience with implant technology that included both polymer and metallic materials.

Joe has participated in industry based initiatives for down-classification of multiple technologies in the cardiovascular & surgical arenas and supported HIMA/Advamed based initiatives against the reuse of single use devices. Technology experience includes: cardiovascular, surgical, orthopedic, gastroenterology, urology, interventional radiology, ophthalmology, and electrophysiology platforms with proven regulatory results. Company experience spans the range of start-up to multi-billion dollar firms that includes: Meadox Medicals, CR BARD, St. Jude Medical, Boston Scientific, CardioFocus and The Curtis Group, LLC.

While at Boston Scientific, Joe had six years of management board experience with two divisions driving $500M in global sales. Joe also had quality assurance responsibility for a Miami-based plant manufacturing over 4 million units/year using injection molded metals. Likewise, he is experienced working with multiple manufacturing sites along with OEM suppliers.

Joe is a long standing member of the Regulatory Affairs Professional Society (RAPS) and is board certified in US regulatory affairs. Locally, Joe has served as Vice-Chairman of the Boston Chapter of RAPS where he supports the continuing education of regulatory professionals as an active member of their Steering Committee and is currently the Program Committee Chair through 2011.